1318 studies found for:    Open Studies | "Genital Diseases, Female"
Show Display Options
Rank Status Study
21 Not yet recruiting A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Gonal-f®;   Drug: Long GnRH agonist;   Drug: GnRH antagonist
22 Recruiting Understanding Adaptive Challenges Associated With Male-factor Infertility
Condition: Male-factor Infertility
23 Not yet recruiting Study of IMGN853 in Comb. With Bevacizumab, Carboplatin or PLD in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer
Conditions: Epithelial Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer;   Endometrial Cancer
Interventions: Drug: IMGN853;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Doxorubicin
24 Not yet recruiting Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease
Condition: Type 1 Von Willebrand Disease
Interventions: Drug: recombinant von Willebrand factor;   Drug: tranexamic acid
25 Recruiting DNA Methylation Biomarkers for Cervical Cancer Screening
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
26 Recruiting Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF)
Condition: Premature Ovarian Failure
Intervention: Biological: Intraovarian injection of Adipose derived Stromal cells (ADSCs)
27 Not yet recruiting Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
Conditions: Opiate Dependence;   Sexually Transmitted Diseases;   HIV
Interventions: Behavioral: Acceptance and Commitment Therapy;   Behavioral: Information Motivation Behavioral Model
28 Not yet recruiting A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Conditions: Malignant Rhabdoid Tumors (MRT);   Rhabdoid Tumors of the Kidney (RTK);   Atypical Teratoid Rhabdoid Tumors (ATRT);   Selected Tumors With Rhabdoid Features;   Synovial Sarcoma;   INI1-negative Tumors;   Malignant Rhabdoid Tumor of Ovary
Intervention: Drug: Tazemetostat
29 Not yet recruiting A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Conditions: Rhabdoid Tumors;   INI1-negative Tumors;   Synovial Sarcoma;   Malignant Rhabdoid Tumor of Ovary
Intervention: Drug: Tazemetostat
30 Recruiting Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas
Condition: Endometriosis
Interventions: Drug: Dienogest;   Drug: Levonorgestrel
31 Not yet recruiting Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence (SENTIRAD).
Condition: Endometrial Carcinoma
Interventions: Drug: Pre-operative Sentinel Node (SN) mapping with Nanocis;   Drug: Intra-operative Sentinel Node (SN) mapping with patent V blue dye;   Drug: Intra-operative Sentinel Node (SN) mapping with indocyanin green (Infracyanine);   Procedure: Full bilateral laparoscopic lymphadenectomy and Hysterectomy
32 Not yet recruiting Gemcitabine Hydrochloride Alone or With VX-970 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Ovarian Serous Tumor;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Drug: ATR Kinase Inhibitor VX-970;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis
33 Not yet recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Vulvar Cancer;   Stage IB2 Cervical Cancer;   Stage II Vulvar Cancer;   Stage IIA1 Cervical Cancer;   Stage IIA2 Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vulvar Cancer;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: High-Dose Rate Brachytherapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Triapine
34 Recruiting Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer
Condition: Cervical Carcinoma Stage IIB
Interventions: Radiation: Concurrent chemoirradiation;   Drug: Paclitaxel;   Procedure: Radical Surgery;   Drug: Cisplatin
35 Recruiting AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
Conditions: Fertility Preservation;   Lymphoma;   Pediatrics Cancer;   Gonadotropin-releasing Hormone Agonist
Intervention: Other: No intervention
36 Recruiting Total/Subtotal Colectomy in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Secondary Malignant Neoplasm of Large Intestine
Interventions: Procedure: Total or Subtotal Colectomy;   Procedure: Other Bowel Resection
37 Recruiting Writing About Experiences With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Writing about ovarian cancer
38 Recruiting Performance and Safety Trial of an Innovative Female Condom (Wondaleaf®)
Conditions: Pregnancy;   Sexually Transmitted Disease
Intervention: Device: Wondaleaf®
39 Not yet recruiting A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
Condition: Platinum-resistant or Refractory Ovarian Cancer
Intervention: Drug: ABT-263
40 Recruiting Adenomyosis and Ulipristal Acetate
Condition: Adenomyosis
Interventions: Drug: Ulipristal acetate;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years